empty
 
 

2024.07.0113:49:00UTC+00IceCure Medical Says FDA Clears Next-Gen XSense Cryoablation System With CryoProbes

IceCure Medical Ltd. (ICCM) announced on Monday that it has received marketing authorization from the U.S. Food and Drug Administration (FDA) for its latest innovation, the XSense Cryoablation System with CryoProbes.

The XSense system and its cryoprobes have been approved for all previously authorized indications of the ProSense system. These include use in general minimally invasive cryoablation procedures across various specialties such as general surgery, dermatology, neurology (including cryoanalgesia), thoracic surgery, ENT, gynecology, oncology, proctology, and urology.

This advanced system is engineered to eliminate tissue through the application of extreme cold, targeting conditions like fibroadenomas, kidney tissue abnormalities, liver metastases, tumors, skin lesions, and warts.

  • Grand Choice
    Contest by
    InstaForex
    InstaForex always strives to help you
    fulfill your biggest dreams.
    JOIN CONTEST
  • Chancy Deposit
    Deposit your account with $3,000 and get $4000 more!
    In July we raffle $4000 within the Chancy Deposit campaign!
    Get a chance to win by depositing $3,000 to a trading account. Having fulfilled this condition, you become a campaign participant.
    JOIN CONTEST
  • Trade Wise, Win Device
    Top up your account with at least $500, sign up for the contest, and get a chance to win mobile devices.
    JOIN CONTEST
  • 30% Bonus
    Receive a 30% bonus every time you top up your account
    GET BONUS


Can't speak right now?
Ask your question in the chat.
Widget callback